FDA Expands Approval for Alnylam’s Drug to Treat Rare Heart Disease
By Reuters The Food and Drug Administration approved Alnylam’s drug to treat a rare and deadly heart disease on Thursday, allowing the entry of a new type of medicine in a market dominated by Pfizer’s blockbuster Vyndaqel. Alnylam is banking on the success of the drug, chemically called vutrisiran, to reach profitability and invest in future treatments. Its drug will compete in the…
More Stories
Kevin Warsh Wants an Overhaul of the Fed—Here’s What That Could Look Like
By Andrew Moran Former Federal Reserve Governor Kevin Warsh has been nominated by President Donald Trump to be the new...
US Forces Shoot Down Iranian Drone Over Arabian Sea
By Ryan Morgan A U.S. fighter jet shot down an Iranian drone as it approached a U.S. aircraft carrier in...
Ex-Husband of Jill Biden Arrested and Charged With Murder
By Zachary Stieber The ex-husband of former First Lady Jill Biden has been arrested in Delaware for allegedly murdering his...
Musk’s SpaceX Acquires xAI to ‘Accelerate Humanity’s Future’
By Troy Myers Two of entrepreneur Elon Musk’s most pioneering companies, SpaceX and xAI, merged Monday with a combined goal...
Groundhog Day 2026: Punxsutawney Phil Spots His Shadow, and You Know What That Means
By Elma Aksalic Punxsutawney Phil, the Pennsylvania groundhog and central figure to the Feb. 2 tradition, delivered a disappointing weather...
Trump Launches $12 Billion ‘Project Vault’ Critical Minerals Stockpile
By Catherine Yang President Donald Trump announced on Feb. 2 a new strategic private sector critical minerals stockpile. “Project Vault”...